E Sturm Selected Research

Cholestasis

1/2002

Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E Sturm Research Topics

Disease

2	Fibrosis (Cirrhosis) 02/2014 - 11/2013
1	Cholestasis 01/2002
1	Intrahepatic Cholestasis 01/2002
1	Pruritus (Itching) 01/2002
1	Melanoma (Melanoma, Malignant) 07/2000
1	Endotoxemia 01/2000
1	Hepatocellular Carcinoma (Hepatoma) 01/2000

Drug/Important Bio-Agent (IBA)

2	Bile Acids and Salts (Bile Acids)IBA 01/2002 - 01/2000
1	MTOR InhibitorsIBA 11/2013
1	ApolipoproteinsIBA 01/2002
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2002
1	AlbuminsIBA 01/2002
1	Coloring Agents (Dyes)IBA 07/2000
1	EndotoxinsIBA 01/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2000
1	Interleukin-6 (Interleukin 6)IBA 01/2000
1	CytokinesIBA 01/2000
1	sodium-bile acid cotransporterIBA 01/2000

Therapy/Procedure

1	Fontan Procedure (Fontan Operation) 02/2014
1	Liver Transplantation 11/2013
1	Therapeutics 01/2002